← Leaderboards
Frederic D Bushman
Children'S Hosp Of Philadelphia
$38,686,561
Attributed
$52,653,236
Total exposure
34
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$61,243,098 · 36
By mechanism
R01$23,975,023 · 10
U19$9,216,537 · 9
U54$6,966,997 · 3
U01$5,869,750 · 2
T32$5,176,464 · 1
UH2$2,257,792 · 1
Top collaborators
- Ronald G Collman16 shared
- James D Lewis5 shared
- Jan J Melenhorst5 shared
- James L Riley5 shared
- Gregory D Van Duyne5 shared
- Gary D. Wu5 shared
- Jason D Christie4 shared
- Denise E Sabatino4 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSamplingSiteGenesBioinformaticsBaseViralComplexDesignGenomeResponseVectorProteinsReportingT-LymphocyteFundingInfectionVirusEvolutionStructureGenomicsGrowthGenetic TranscriptionPathogenesis
Grant awards (129)
The Oro-Respiratory-Gut Virome Axis Over Space and Time$4,000,000
U54 · FY2025 · AG
mVACS--mRNA Vaccines for C. difficile Suppression$1,529,954
U19 · FY2025 · AI · contact PI
Biospeciman Analysis Core$1,497,442
U54 · FY2025 · AG · contact PI
Defining and then Maximizing the Footprint of CTL Selection on HIV Integration Site Landscapes to Optimize Cure Strategies$829,575
R37 · FY2025 · AI
Preserving Genome Integrity In AAV-Mediated Gene Therapy$645,239
R01 · FY2025 · HL
Core B. Genomics and Bioinformatics Core$254,993
U19 · FY2025 · AI · contact PI
Genome Engineering Core$243,747
P01 · FY2025 · AI · contact PI
mVACS--mRNA Vaccines for C. difficile Suppression$1,529,954
U19 · FY2024 · AI · contact PI
Defining and then Maximizing the Footprint of CTL Selection on HIV Integration Site Landscapes to Optimize Cure Strategies$864,325
R37 · FY2024 · AI
Preserving Genome Integrity In AAV-Mediated Gene Therapy$632,334
R01 · FY2024 · HL
HIV Pathogenesis, Vaccination and Cure$492,527
T32 · FY2024 · AI · contact PI
Core B. Genomics and Bioinformatics Core$172,353
U19 · FY2024 · AI · contact PI
Core B: Genome Engineering Core$168,613
U19 · FY2024 · AI · contact PI
mVACS--mRNA Vaccines for C. difficile Suppression$1,529,954
U19 · FY2023 · AI · contact PI
Preserving Genome Integrity In AAV-Mediated Gene Therapy$645,239
R01 · FY2023 · HL
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$592,071
R01 · FY2023 · CA · contact PI
HIV Pathogenesis, Vaccination and Cure$516,516
T32 · FY2023 · AI · contact PI
Core B. Genomics and Bioinformatics Core$167,770
U19 · FY2023 · AI · contact PI
Core B: Genome Engineering Core$160,254
U19 · FY2023 · AI · contact PI
Preserving Genome Integrity In AAV-Mediated Gene Therapy$631,452
R01 · FY2022 · HL
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$600,298
R01 · FY2022 · CA · contact PI
HIV Pathogenesis, Vaccination and Cure$500,633
T32 · FY2022 · AI · contact PI
Core B: Genome Engineering Core$166,471
U19 · FY2022 · AI · contact PI
The Lung DNA Virome in Health and Disease$736,351
R33 · FY2021 · HL
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$621,091
R01 · FY2021 · CA · contact PI
HIV Pathogenesis, Vaccination and Cure$500,670
T32 · FY2021 · AI · contact PI
Optimization HIV Inhibition by Allosteric Integrase Inhibitors$434,303
R01 · FY2021 · AI · contact PI
Core B: Genome Engineering Core$161,705
U19 · FY2021 · AI · contact PI
The Lung DNA Virome in Health and Disease$749,556
R33 · FY2020 · HL
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$619,360
R01 · FY2020 · CA · contact PI
HIV Pathogenesis, Vaccination and Cure$483,175
T32 · FY2020 · AI · contact PI
Optimization HIV Inhibition by Allosteric Integrase Inhibitors$434,303
R01 · FY2020 · AI · contact PI
Core B: Genome Engineering Core$162,000
U19 · FY2020 · AI · contact PI
The Lung DNA Virome in Health and Disease$764,563
R33 · FY2019 · HL
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$618,579
R01 · FY2019 · CA · contact PI
Training in HIV pathogenesis$445,815
T32 · FY2019 · AI · contact PI
Optimization HIV Inhibition by Allosteric Integrase Inhibitors$434,303
R01 · FY2019 · AI · contact PI
Sequencing and Viral Evolution Core$155,200
U19 · FY2019 · AI · contact PI
Training in HIV pathogenesis$454,590
T32 · FY2018 · AI · contact PI
Optimization HIV Inhibition by Allosteric Integrase Inhibitors$434,303
R01 · FY2018 · AI · contact PI
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer$398,081
R01 · FY2018 · AI · contact PI
The Lung DNA Virome in Health and Disease$269,522
R61 · FY2018 · HL
Sequencing and Viral Evolution Core$158,400
U19 · FY2018 · AI · contact PI
The Lung DNA Virome in Health and Disease$62,943
R61 · FY2018 · HL
Optimization HIV Inhibition by Allosteric Integrase Inhibitors$434,303
R01 · FY2017 · AI · contact PI
Training in HIV pathogenesis$410,155
T32 · FY2017 · AI · contact PI
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer$398,092
R01 · FY2017 · AI · contact PI
Favored sites for HIV cDNA integration in the human genome$393,590
R01 · FY2017 · AI · contact PI
The Lung DNA Virome in Health and Disease$272,742
R61 · FY2017 · HL
Sequencing and Viral Evolution Core$271,334
U19 · FY2017 · AI · contact PI
Lung Transplant Microbiome and Chronic Allograft Dysfunction$726,955
R01 · FY2016 · HL
Favored sites for HIV cDNA integration in the human genome$494,754
R01 · FY2016 · AI · contact PI
Training in HIV pathogenesis$468,545
T32 · FY2016 · AI · contact PI
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer$398,102
R01 · FY2016 · AI · contact PI
Sequencing and Viral Evolution Core$164,776
U19 · FY2016 · AI · contact PI
Lung Transplant Microbiome and Chronic Allograft Dysfunction$729,685
R01 · FY2015 · HL
Training in HIV pathogenesis$455,115
T32 · FY2015 · AI · contact PI
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer$398,114
R01 · FY2015 · AI · contact PI
Favored sites for HIV cDNA integration in the human genome$393,590
R01 · FY2015 · AI · contact PI
Sequencing and Viral Evolution Core$172,193
U19 · FY2015 · AI · contact PI
Lung Transplant Microbiome and Chronic Allograft Dysfunction$736,861
R01 · FY2014 · HL
Training in HIV Pathogenesis$448,723
T32 · FY2014 · AI · contact PI
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer$413,124
R01 · FY2014 · AI · contact PI
Favored sites for HIV cDNA integration in the human genome$393,590
R01 · FY2014 · AI · contact PI
Lung Transplant Microbiome and Chronic Allograft Dysfunction$742,869
R01 · FY2013 · HL
Human Respiratory Tract Microbiome in Health, HIV Infection and HIV Lung Disease$704,201
U01 · FY2013 · HL
Favored sites for HIV cDNA integration in the human genome$384,974
R01 · FY2013 · AI · contact PI
Inhibition of DNA modifying enzymes of category A-C agents$256,262
U54 · FY2013 · AI · contact PI
Sequencing and Viral Evolution Core$195,911
U19 · FY2013 · AI · contact PI
Human Respiratory Tract Microbiome in Health, HIV Infection and HIV Lung Disease$799,878
U01 · FY2012 · HL
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease$721,709
UH3 · FY2012 · DK
Favored sites for HIV cDNA integration in the human genome$491,451
R01 · FY2012 · AI · contact PI
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer$363,206
R01 · FY2012 · AI · contact PI
Inhibition of DNA modifying enzymes of category A-C agents$296,221
U54 · FY2012 · AI · contact PI
Sequencing and Viral Evolution Core$212,170
U19 · FY2012 · AI · contact PI
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease$176,000
UH3 · FY2012 · DK
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease$806,740
UH3 · FY2011 · DK
Human Respiratory Tract Microbiome in Health, HIV Infection and HIV Lung Disease$804,577
U01 · FY2011 · HL
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer$363,026
R01 · FY2011 · AI · contact PI
Favored sites for HIV cDNA integration in the human genome$331,896
R01 · FY2011 · AI · contact PI
Inhibition of DNA modifying enzymes of category A-C agents$305,162
U54 · FY2011 · AI · contact PI
Sequencing and Viral Evolution Core$251,352
U19 · FY2011 · AI · contact PI
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease$1,128,896
UH2 · FY2010 · DK
Broad spectrum therapeutics targeting resolvase enzymes$942,460
U01 · FY2010 · AI · contact PI
Human Respiratory Tract Microbiome in Health, HIV Infection and HIV Lung Disease$804,838
U01 · FY2010 · HL
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer$366,650
R01 · FY2010 · AI · contact PI
Favored sites for HIV cDNA integration in the human genome$335,699
R01 · FY2010 · AI · contact PI
Inhibition of DNA modifying enzymes of category A-C agents$311,943
U54 · FY2010 · AI · contact PI
Sequencing and Viral Evolution Core$259,660
U19 · FY2010 · AI · contact PI
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease$1,128,896
UH2 · FY2009 · DK
Broad spectrum therapeutics targeting resolvase enzymes$1,012,363
U01 · FY2009 · AI · contact PI
Human Respiratory Tract Microbiome in Health, HIV Infection and HIV Lung Disease$801,433
U01 · FY2009 · HL
Massively Parallel Analysis of Integration in Therapeutic Gene Transfer$384,890
R01 · FY2009 · AI · contact PI
Favored sites for HIV cDNA integration in the human genome$339,536
R01 · FY2009 · AI · contact PI
Inhibition of DNA modifying enzymes of category A-C agents$299,967
U54 · FY2009 · AI · contact PI
Sequencing and Viral Evolution Core$272,743
U19 · FY2009 · AI · contact PI
THE MACAQUE GUT MICROBIOME IN HEALTH, LENTIVIRAL INFECTION AND IBD$62,691
P51 · FY2009 · RR · contact PI
Purchase of the Roche GS SLX Sequencing System$500,000
S10 · FY2008 · RR · contact PI
Favored sites for HIV cDNA integration in the human genome$354,342
R01 · FY2008 · AI · contact PI
Lentiviral Vector Integration in the Clinic$340,762
U19 · FY2008 · AI · contact PI
THE MACAQUE GUT MICROBIOME IN HEALTH, LENTIVIRAL INFECTION AND IBD$63,253
P51 · FY2008 · RR · contact PI
Lentiviral Vector Integration in the Clinic$298,656
U19 · FY2007 · AI · contact PI
Chemistry of HIV-1 Integrase Function$252,481
R01 · FY2007 · GM · contact PI
THE MACAQUE GUT MICROBIOME IN HEALTH, LENTIVIRAL INFECTION AND IBD$71,638
P51 · FY2007 · RR · contact PI
Lentiviral Vector Integration in the Clinic$313,603
U19 · FY2006 · AI · contact PI
Favored Sites for HIV Integration in the Human Genome$271,843
R01 · FY2006 · AI · contact PI
Chemistry of HIV-1 Integrase Function$260,022
R01 · FY2006 · GM · contact PI
Mechanism of HIV DNA Integration$356,625
R01 · FY2005 · AI
Favored Sites for HIV Integration in the Human Genome$286,481
R01 · FY2005 · AI
Chemistry of HIV-1 Integrase Function$266,280
R01 · FY2005 · GM
Lentiviral Vector Integration in the Clinic$145,756
U19 · FY2005 · AI
Mechanism of HIV DNA Integration$356,625
R01 · FY2004 · AI
Chemistry of HIV-1 Integrase Function$266,280
R01 · FY2004 · GM
Favored Sites for HIV Integration in the Human Genome$192,933
R01 · FY2004 · AI
Favored Sites for HIV Integration in the Human Genome$130,793
R01 · FY2004 · AI
Favored Sites for HIV Integration in the Human Genome$378,862
R01 · FY2003 · AI
Mechanism of HIV DNA Integration$293,564
R01 · FY2003 · AI
Host Cell Response to the Early Steps of Hiv Infection$237,750
R21 · FY2003 · AI
Mechanism of HIV DNA Integration$106,195
R01 · FY2003 · AI
Host Cell Response to the Early Steps of Hiv Infection$65,730
R21 · FY2003 · AI
Mechanism of HIV DNA Integration$418,050
R01 · FY2002 · AI
Favored Sites for HIV Integration in the Human Genome$379,400
R01 · FY2002 · AI
Host Cell Response to the Early Steps of Hiv Infection$281,700
R21 · FY2002 · AI
MOLLUSCUM CONTAGIOSUM VIRUS TOPOISOMERASE$228,520
R01 · FY2002 · AI
Mechanism of HIV DNA Integration$397,148
R01 · FY2001 · AI
MOLLUSCUM CONTAGIOSUM VIRUS TOPOISOMERASE$221,861
R01 · FY2001 · AI
MECHANISM OF HIV DNA INTEGRATION$345,516
R01 · FY2000 · AI
MODIFYING HIV TO INTEGRATE AT PRESELECTED DNA SITES$239,889
R01 · FY2000 · AI
MOLLUSCUM CONTAGIOSUM VIRUS TOPOISOMERASE$215,400
R01 · FY2000 · AI